394 related articles for article (PubMed ID: 2749729)
1. Physiologically based pharmacokinetic modeling of the pregnant rat: a multiroute exposure model for trichloroethylene and its metabolite, trichloroacetic acid.
Fisher JW; Whittaker TA; Taylor DH; Clewell HJ; Andersen ME
Toxicol Appl Pharmacol; 1989 Jul; 99(3):395-414. PubMed ID: 2749729
[TBL] [Abstract][Full Text] [Related]
2. Physiologically based pharmacokinetic modeling of the lactating rat and nursing pup: a multiroute exposure model for trichloroethylene and its metabolite, trichloroacetic acid.
Fisher JW; Whittaker TA; Taylor DH; Clewell HJ; Andersen ME
Toxicol Appl Pharmacol; 1990 Mar; 102(3):497-513. PubMed ID: 2315918
[TBL] [Abstract][Full Text] [Related]
3. Physiologically based pharmacokinetic modeling with trichloroethylene and its metabolite, trichloroacetic acid, in the rat and mouse.
Fisher JW; Gargas ML; Allen BC; Andersen ME
Toxicol Appl Pharmacol; 1991 Jun; 109(2):183-95. PubMed ID: 2068722
[TBL] [Abstract][Full Text] [Related]
4. A physiologically based pharmacokinetic model for trichloroethylene and its metabolites, chloral hydrate, trichloroacetate, dichloroacetate, trichloroethanol, and trichloroethanol glucuronide in B6C3F1 mice.
Abbas R; Fisher JW
Toxicol Appl Pharmacol; 1997 Nov; 147(1):15-30. PubMed ID: 9356303
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic modeling of trichloroethylene and trichloroacetic acid in humans.
Allen BC; Fisher JW
Risk Anal; 1993 Feb; 13(1):71-86. PubMed ID: 8451462
[TBL] [Abstract][Full Text] [Related]
6. Physiologically based pharmacokinetic modeling of inhaled trichloroethylene and its oxidative metabolites in B6C3F1 mice.
Greenberg MS; Burton GA; Fisher JW
Toxicol Appl Pharmacol; 1999 Feb; 154(3):264-78. PubMed ID: 9931286
[TBL] [Abstract][Full Text] [Related]
7. Trichloroethylene, trichloroacetic acid, and dichloroacetic acid: do they affect fetal rat heart development?
Fisher JW; Channel SR; Eggers JS; Johnson PD; MacMahon KL; Goodyear CD; Sudberry GL; Warren DA; Latendresse JR; Graeter LJ
Int J Toxicol; 2001; 20(5):257-67. PubMed ID: 11766123
[TBL] [Abstract][Full Text] [Related]
8. Physiological pharmacokinetic modeling of inhaled trichloroethylene in rats.
Dallas CE; Gallo JM; Ramanathan R; Muralidhara S; Bruckner JV
Toxicol Appl Pharmacol; 1991 Sep; 110(2):303-14. PubMed ID: 1891776
[TBL] [Abstract][Full Text] [Related]
9. Trichloroacetic acid: updated estimates of its bioavailability and its contribution to trichloroethylene-induced mouse hepatomegaly.
Chiu WA
Toxicology; 2011 Jul; 285(3):114-25. PubMed ID: 21549800
[TBL] [Abstract][Full Text] [Related]
10. Physiologically based pharmacokinetic models for trichloroethylene and its oxidative metabolites.
Fisher JW
Environ Health Perspect; 2000 May; 108 Suppl 2(Suppl 2):265-73. PubMed ID: 10807557
[TBL] [Abstract][Full Text] [Related]
11. A human physiologically based pharmacokinetic model for trichloroethylene and its metabolites, trichloroacetic acid and free trichloroethanol.
Fisher JW; Mahle D; Abbas R
Toxicol Appl Pharmacol; 1998 Oct; 152(2):339-59. PubMed ID: 9853003
[TBL] [Abstract][Full Text] [Related]
12. Development of an updated PBPK model for trichloroethylene and metabolites in mice, and its application to discern the role of oxidative metabolism in TCE-induced hepatomegaly.
Evans MV; Chiu WA; Okino MS; Caldwell JC
Toxicol Appl Pharmacol; 2009 May; 236(3):329-40. PubMed ID: 19249323
[TBL] [Abstract][Full Text] [Related]
13. A physiologically based pharmacokinetic model for trichloroethylene in the male long-evans rat.
Simmons JE; Boyes WK; Bushnell PJ; Raymer JH; Limsakun T; McDonald A; Sey YM; Evans MV
Toxicol Sci; 2002 Sep; 69(1):3-15. PubMed ID: 12215655
[TBL] [Abstract][Full Text] [Related]
14. Trichloroethylene in drinking water throughout gestation did not produce congenital heart defects in Sprague Dawley rats.
DeSesso JM; Coder PS; York RG; Budinsky RA; Pottenger LH; Sen S; Lucarell JM; Bevan C; Bus JS
Birth Defects Res; 2019 Oct; 111(16):1217-1233. PubMed ID: 31197966
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic analysis of trichloroethylene metabolism in male B6C3F1 mice: Formation and disposition of trichloroacetic acid, dichloroacetic acid, S-(1,2-dichlorovinyl)glutathione and S-(1,2-dichlorovinyl)-L-cysteine.
Kim S; Kim D; Pollack GM; Collins LB; Rusyn I
Toxicol Appl Pharmacol; 2009 Jul; 238(1):90-9. PubMed ID: 19409406
[TBL] [Abstract][Full Text] [Related]
16. Tissue dosimetry expansion and cross-validation of rat and mouse physiologically based pharmacokinetic models for trichloroethylene.
Keys DA; Bruckner JV; Muralidhara S; Fisher JW
Toxicol Sci; 2003 Nov; 76(1):35-50. PubMed ID: 12915716
[TBL] [Abstract][Full Text] [Related]
17. Quantitative evaluation of the metabolic interactions between trichloroethylene and 1,1-dichloroethylene in vivo using gas uptake methods.
Andersen ME; Gargas ML; Clewell HJ; Severyn KM
Toxicol Appl Pharmacol; 1987 Jun; 89(2):149-57. PubMed ID: 3603553
[TBL] [Abstract][Full Text] [Related]
18. A trichloroethylene risk assessment using a Monte Carlo analysis of parameter uncertainty in conjunction with physiologically-based pharmacokinetic modeling.
Cronin WJ; Oswald EJ; Shelley ML; Fisher JW; Flemming CD
Risk Anal; 1995 Oct; 15(5):555-65. PubMed ID: 7501875
[TBL] [Abstract][Full Text] [Related]
19. Evaluating the risk of liver cancer in humans exposed to trichloroethylene using physiological models.
Fisher JW; Allen BC
Risk Anal; 1993 Feb; 13(1):87-95. PubMed ID: 8451463
[TBL] [Abstract][Full Text] [Related]
20. Physiologically based pharmacokinetic modeling with dichloromethane, its metabolite, carbon monoxide, and blood carboxyhemoglobin in rats and humans.
Andersen ME; Clewell HJ; Gargas ML; MacNaughton MG; Reitz RH; Nolan RJ; McKenna MJ
Toxicol Appl Pharmacol; 1991 Mar; 108(1):14-27. PubMed ID: 1900959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
